Your browser doesn't support javascript.
loading
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.
Frisell, T; Forsberg, L; Nordin, N; Kiesel, C; Alfredsson, L; Askling, J; Hillert, J; Olsson, T; Piehl, F.
Afiliação
  • Frisell T; Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Solna, Sweden thomas.frisell@ki.se.
  • Forsberg L; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
  • Nordin N; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
  • Kiesel C; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
  • Alfredsson L; Institute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.
  • Askling J; Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Solna, Sweden/Rheumatology Unit, Department of Medicine, Karolinska Institutet, Solna, Sweden.
  • Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
  • Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
  • Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Mult Scler ; 22(1): 85-93, 2016 Jan.
Article em En | MEDLINE | ID: mdl-25921036
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros / Cloridrato de Fingolimode / Natalizumab / Fatores Imunológicos / Esclerose Múltipla Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros / Cloridrato de Fingolimode / Natalizumab / Fatores Imunológicos / Esclerose Múltipla Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article